FDA starts pilot scheme to secure medicine imports SecuringIndustry -Phil Taylor - 20Feb2014
The main thrust of the two-year effort is to test the approach in a selected group of companies that are certified as maintaining high manufacturing and supply chain standards and so qualify for expedited entry for shipments of imported medicines.
The 13 pre-qualified companies accepted into the pilot and which will qualify for expedited entry of up to five products each, are:
AbbVie Allergan Astellas US Technologies Bristol-Myers Squibb Celgene GE Healthcare GlaxoSmithKline Merck Sharp & Dohme Mylan Pharmaceuticals Novartis Pharmaceuticals Pfizer Teva Pharmaceuticals USA Watson Laboratories
Market Data 
Markets 
AI
